Article thumbnail

The First Negative Allosteric Modulator for Dopamine D 2 and D 3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs

By Mario Rossi, Irene Fasciani, Francesco Marampon, Roberto Maggio and Marco Scarselli
Publisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)
Year: 2017
DOI identifier: 10.1124/mol.116.107607
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.